These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8518037)

  • 1. Phase II trial of iproplatin in advanced squamous cell carcinoma of the head and neck, oesophagus and lung.
    Cappelaere P; Guiochet N; Bastit P; Favre R; Vanderburg M; Goupil A; Chauvergne J; Thomas D; Van Glabbeke M; Armand JP
    Eur J Cancer; 1993; 29A(8):1216. PubMed ID: 8518037
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck.
    Abele R; Clavel M; Monfardini S; Bruntsch U; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):387-9. PubMed ID: 3609103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Degardin M; Cappelaere P; Krakowski I; Fargeot P; Cupissol D; Brienza S
    Eur J Cancer B Oral Oncol; 1996 Jul; 32B(4):278-9. PubMed ID: 8776427
    [No Abstract]   [Full Text] [Related]  

  • 4. Carboplatin: current status and future prospects.
    Canetta R; Bragman K; Smaldone L; Rozencweig M
    Cancer Treat Rev; 1988 Jun; 15 Suppl B():17-32. PubMed ID: 2841021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin, an active drug in advanced head and neck cancer.
    de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
    Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the anti-tumor effects of CDDP derivatives on head and neck squamous cell carcinoma cell lines].
    Tsukuda M; Yoshida T; Kubota A; Yanoma S; Watanabe S; Takahashi K; Ono T; Sawaki S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2811-4. PubMed ID: 3415274
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical screening cooperative group phase II evaluation of lobaplatin (ASTA D-19466) in advanced head and neck cancer.
    Degardin M; Armand JP; Chevallier B; Cappelaere P; Lentz MA; David M; Roché H
    Invest New Drugs; 1995; 13(3):253-5. PubMed ID: 8729955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
    Kies MS
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S52-9. PubMed ID: 19780246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin: the clinical spectrum to date.
    Canetta R; Rozencweig M; Carter SK
    Cancer Treat Rev; 1985 Sep; 12 Suppl A():125-36. PubMed ID: 3002623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin in the treatment of oesophageal cancer.
    Mannell A; Winters Z
    S Afr Med J; 1989 Sep; 76(5):213-4. PubMed ID: 2672377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of nedaplatin prior to S-1 in patients with locally advanced head and neck squamous cell carcinoma.
    Sato D; Kogashiwa Y; Tsukahara K; Yamauchi K; Kohno N
    Chemotherapy; 2013; 59(4):314-8. PubMed ID: 24480865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of carboplatin in advanced esophageal carcinoma. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society.
    Queisser W; Preusser P; Mross KB; Fritze D; Rieche K; Beyer JH; Achterrath W; Edler L
    Onkologie; 1990 Jun; 13(3):190-3. PubMed ID: 2204004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases.
    Bensen R; Brognard J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck.
    Eisenberger M; Hornedo J; Silva H; Donehower R; Spaulding M; Van Echo D
    J Clin Oncol; 1986 Oct; 4(10):1506-9. PubMed ID: 3531424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: a phase II feasibility study.
    Raguse JD; Gath HJ; Oettle H; Bier J
    Oral Oncol; 2006 Jul; 42(6):614-8. PubMed ID: 16488656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials with bleomycin in lymphomas and in solid tumors.
    Bonadonna G; De Lena M; Monfardini S; Bartoli C; Bajetta E; Beretta G; Fossati-Bellani F
    Eur J Cancer (1965); 1972 Apr; 8(2):205-15. PubMed ID: 4116302
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
    McGuire WP; Arseneau J; Blessing JA; DiSaia PJ; Hatch KD; Given FT; Teng NN; Creasman WT
    J Clin Oncol; 1989 Oct; 7(10):1462-8. PubMed ID: 2674333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioproline (Norgamem): a useless drug in the treatment of squamous cell carcinoma.
    Alberto P
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1061-2. PubMed ID: 7198987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.